As of 2026-02-13, the Intrinsic Value of Vor Biopharma Inc (VOR) is -559.00 USD. This VOR valuation is based on the model Peter Lynch Fair Value. With the current market price of 13.34 USD, the upside of Vor Biopharma Inc is -4,290.44%.
Based on its market price of 13.34 USD and our intrinsic valuation, Vor Biopharma Inc (VOR) is overvalued by 4,290.44%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -559.00 - -559.00 | -559.00 | -4,290.44% |
| P/E | (1,963.22) - (1,833.53) | (1,911.79) | -14431.3% |
| DDM - Stable | (1,276.82) - (6,766.97) | (4,021.90) | -30249.2% |
| DDM - Multi | (9.87) - (40.49) | (15.84) | -218.7% |
| Market Cap (mil) | 292.28 |
| Beta | 7.07 |
| Outstanding shares (mil) | 21.91 |
| Enterprise Value (mil) | 131.82 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.81% |
| Cost of Debt | 5.00% |
| WACC | 5.74% |